Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

ADR Spinal Restoration Center Opens Up 2-Level prodisc® and 1-Level Synergy Disc® Clinical Trials in Los Angeles
  • USA - English

Those experiencing symptoms after trying non-operative conservative treatments may find themselves to be candidates for a motion-preserving alternative to spinal fusion in a new FDA clinical study.


News provided by

ADR Spinal Restoration Center

May 21, 2021, 18:00 ET

Share this article

Share toX

Share this article

Share toX

LOS ANGELES, May 21, 2021 /PRNewswire-PRWeb/ -- Those suffering from painful degenerative or herniated discs in their necks might find relief in two newly launched clinical studies at the Beverly Hills-based Advanced Disc Replacement Spinal Restoration Center | Lanman Spinal Neurosurgery, operated by leading spinal surgeon and spine medicine innovator, Dr. Todd Lanman.

Earlier this year, the practice has begun enrollment on two new clinical research trials, featuring artificial cervical disc devices by Centinel Spine and Synergy Spine Solutions.

For those experiencing continued symptoms from arm or neck pain after trying non-operative conservative treatments such as physical therapy and medication, they may find themselves to be candidates for a motion-preserving alternative to spinal fusion in a new FDA clinical study using the prodisc C Vivo and SK.

The 2-to-1 randomized clinical trial is investigating the treatment of two-level symptomatic cervical disc disease, comparing both the Vivo and SK to the Mobi-C in those between the ages of 18-69. The Mobi-C device is used as the control to determine the safety and efficacy of the two prodisc C discs to treat disc disease at two levels of the cervical spine.

For every two patients receiving a prodisc C Vivo or SK, a third will receive a currently marketed and approved TDR (total disc replacement) Mobi-C device.

Both prodisc devices are low profile, which allow for stacking (or multilevel application) at two adjacent levels of the cervical spine, and have a ball and socket design, allowing for physiological range of motion and stability. The C Vivo incorporates a "teeth" fixation, while the SK uses low-profile keels for fixation.

During the surgery, for those receiving the prodisc, Dr. Lanman will select the appropriate design correlating with the patient's anatomic needs.

For those patients needing a single-level disc replacement, the Synergy Cervical Disc Investigational Device (IDE) Clinical Trial might be a better suited option.

The Synergy Disc trial is a historically-controlled study designed to demonstrate that the Synergy device is as safe and effective as conventional anterior cervical discectomy and fusion in patients experiencing symptomatic degenerative disc disease in one level of their cervical spine. What is also unique about this trial is that patients who have had a prior cervical fusion at one level can be in the Synergy Disc trial. You may qualify for this trial if you have a single degenerative disc in your neck or need a disc replacement after having had a fusion in your neck. All patients who qualify for that study will receive the Synergy Disc.

Synergy was founded by Dr. Neil Duggal, M.D., a Canadian neurosurgeon who has dedicated his neurosurgery practice to advancing the treatment of patients with symptomatic cervical degenerative disc disease and myelopathy. Synergy has received more than 55 patents, protecting its novel design elements and features of alignment and motion restoration.

The Synergy Disc is a cervical disc prothesis that is intended for reconstruction of a disc between C3-C7 after a single level discectomy, in order to provide restoration of motion and alignment to the functional spinal unit.

For nearly three decades, Dr. Lanman has been at the forefront of innovation in the world of spine medicine, particularly when it pertains to motion preservation and advanced disc replacement. He has served as principal investigator on a majority of clinical trials for artificial disc replacement devices, leading to their FDA approvals.

Dr. Lanman has served as an associate professor at UCLA for more than 20 years and has published numerous peer-reviewed articles and book chapters. He serves as a medical educator and expert contributor and is sought after by patients from around the world, including high-profile celebrities and business leaders. His practice, Lanman Spinal Neurosurgery, is affiliated with Cedars-Sinai Medical Center's Institute for Spinal Disorders and UCLA Medical Center.

For more information on ADR Spinal Restoration Center, visit http://www.adrspine.com / For more information on Lanman Spinal Neurosurgery, visit http://www.spine.md.

Media Contact

Steven LeVine, Brandi Kamenar Beverly Hills, +1 323-386-2300 Ext: 1, [email protected]

SOURCE ADR Spinal Restoration Center

Related Links

http://www.adrspine.com

Modal title

Dr. Todd H. Lanman, Lanman Spinal Neurosurgery
Dr. Todd H. Lanman, Lanman Spinal Neurosurgery
Dr. Todd H. Lanman, Lanman Spinal Neurosurgery

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.